TLDR Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.
The study investigated the impact of sex hormones, age, and cardiovascular disease on the expression of ACE-2 and TMPRSS-2 proteins, which are key for SARS-CoV-2 entry into cells, using murine models. It found that sex and gonadal hormones did not significantly affect the expression of these proteins in lung tissue, even after myocardial injury. Age, however, did impact expression, with younger mice showing higher ACE-2 expression after myocardial injury and lower TMPRSS-2 expression under both baseline and post-injury conditions. In kidney and liver tissues, female sex was associated with lower levels of ACE-2 and TMPRSS-2 expression after myocardial injury. The study also found that female reproductive history did not impact the pulmonary expression levels of these proteins. The study suggests that the higher COVID-19 mortality in males may be due to differences in immune status associated with cardiovascular comorbidities, rather than differences in ACE-2 expression.
49 citations,
January 2021 in “Journal of The European Academy of Dermatology and Venereology” Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.
36 citations,
November 2020 in “Journal of The European Academy of Dermatology and Venereology” 5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.
119 citations,
May 2020 in “Journal of The American Academy of Dermatology” Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
134 citations,
April 2020 in “Journal of Cosmetic Dermatology” Male pattern hair loss could hint at androgens affecting COVID-19 severity.
34 citations,
September 2020 in “BMC Endocrine Disorders” Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.
11 citations,
May 2021 in “Journal of Medical Virology” Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.
19 citations,
November 2021 in “Reviews in endocrine and metabolic disorders” Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.
125 citations,
August 2020 in “Frontiers in Immunology” Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.
15 citations,
August 2021 in “Reviews in endocrine and metabolic disorders” COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.
